Sekisui XenoTech Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:N/A
Lead Investor(s):N/A

State Ranking

Estimated Revenue & Financials

  • Sekisui XenoTech's estimated annual revenue is currently $32.4M per year.
  • Sekisui XenoTech's estimated revenue per employee is $201,000

Employee Data

  • Sekisui XenoTech has 161 Employees.
  • Sekisui XenoTech grew their employee count by 0% last year.
  • Sekisui XenoTech currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingPricing
Sparhawk Labora...
Sekisui XenoTec...
Fagron Sterile ...
cGMP Validation...
KCAS Bioanalyti...
American Colleg...
ProPharma Group
Missing a competitor? Contribute!?

Sekisui XenoTech is a global Contract Research Organization (CRO) serving clients with unparalleled experience and expertise in evaluating drug candidates, nutraceuticals, cosmetics, food additives and other compounds known as xenobiotics as substrates, inhibitors and inducers of cytochrome P450, UGT and other drug metabolizing enzymes, as well as drug transporters. We offer a variety of in vitro and in vivo safety assessment studies for drug candidate evaluation, as well as an extensive selection of products for drug metabolism research. Sekisui XenoTech's product selection includes a wide-range of high quality standard reagents, from subcellular fractions and hepatocytes to recombinant enzymes, substrates and metabolites. The company can also prepare and deliver custom-designed products and services in respnose to client requests. Sekisui XenoTech has extensive experience with the US FDA, EMA and MHLW governing bodies.



Number of Employees


Revenue (est)


Current Jobs


Employee Growth %


Total Funding







Executive Contacts

April DowneyGlobal Technical and Scientific Support Manager
Greg LoewenDirector Of Business Development And Technical Advisor
Lois HauptPrincipal Scientist
Scott HickmanDirector, Global Marketing
Seema MuranjanDirector, Analytical Services
Michael MillhollenGlobal Marketing Manager
Rebecca CampbellPrincipal Scientist
Brian OgilvieVice President of Scientific Consulting
Joanna BarbaraVice President - Scientific Operations
Teresa MartinAccount Manager

Sekisui XenoTech News

09/05/2019 - SEKISUI XenoTech Announces Expanded Consultation For ...

SEKISUI XenoTech has announced the opportunity for clients to work with top-tier consultants to analyze critical components of absorption, ...

07/03/2019 - SEKISUI XenoTech Announces Enhanced Synergy in ADME ...

SEKISUI XenoTech is collaborating with the Drug Development Solutions Center to offer a full suite of nonclinical testing services specializing ...

01/06/2019 - Sekisui XenoTech Announces Creation of Scientific Advisory ...

Sekisui XenoTech has created a Scientific Advisory Board (SAB) of renowned scientists and thought leaders in the pharmaceutical industry.

Sekisui XenoTech Executive Hires

2017-10-23Darren WarrenCOOArticle